BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/15/2026 6:06:26 AM | Browse: 3 | Download: 25
 |
Received |
|
2025-09-22 02:01 |
 |
Peer-Review Started |
|
2025-09-22 02:01 |
 |
First Decision by Editorial Office Director |
|
2025-10-29 09:20 |
 |
Return for Revision |
|
2025-10-29 09:20 |
 |
Revised |
|
2025-11-06 17:24 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2025-12-29 02:32 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2025-12-29 06:56 |
 |
Articles in Press |
|
2025-12-29 06:56 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2026-01-23 08:23 |
 |
Publish the Manuscript Online |
|
2026-03-15 06:06 |
| ISSN |
2220-315x (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mohamed Wishahi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed Wishahi, MD, PhD, Professor, Department of Urology, Theodor Bilharz Research Institute, Embaba, Giza, Cairo 12411, Egypt. moh.weshahy@gmail.com |
| Key Words |
Leukoplakia; Squamous cell carcinoma; Programmed cell death-ligand 1; Immune checkpoint inhibitors; Oral cancer; Bladder cancer |
| Core Tip |
Oral leukoplakia and urinary bladder leukoplakia are premalignant lesions that progress to squamous cell carcinoma (SCC), both lesions and their corresponding SCC express programmed cell death-ligand 1 (PD-L1) indicating response to PD-L1 inhibitors. A recent approach with consideration of recent finding of expression of PD-L1, genetic analysis, microenvironment landscape, recruited clinical trials, and animal model studies would advocate possible treatment of oral leukoplakia with PD-L1 inhibitors aiming at cure and prevent progression to SCC. |
| Publish Date |
2026-03-15 06:06 |
| Citation |
Wishahi M. Leukoplakia of oral cavity and urinary bladder are premalignant to squamous carcinoma. World J Exp Med 2026; 16(1): 114526 |
| URL |
https://www.wjgnet.com/2220-315x/full/v16/i1/114526.htm |
| DOI |
https://dx.doi.org/10.5493/wjem.v16.i1.114526 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345